RetinalGenix Technologies Inc. Stock
Stocks
RTGN
US76133Y1055
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
22:46:02 30/10/2025 +04
|
5-day change | 1st Jan Change | ||
| 3.550 USD | -11.25% |
|
-11.03% | +10.94% |
| Market Cap | 75.19M 66.8M 62.35M 56.83M 107M 7.23B 108M 755M 292M 3.69B 282M 276M 11.86B | P/E 2024 |
-21.8x | P/E 2025 | -24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 75.72M 67.27M 62.79M 57.23M 108M 7.28B 109M 760M 294M 3.72B 284M 278M 11.94B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
34.7% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -11.25% | ||
| 1 week | -11.03% | ||
| Current month | -11.03% | ||
| 1 month | -11.25% | ||
| 3 months | -11.25% | ||
| 6 months | +10.94% | ||
| Current year | +10.94% |
| 1 month | 3.55 |  | 4 |
| Current year | 3.55 | | 4 |
| 1 year | 3.2 | | 4.01 |
| 3 years | 0.25 | | 6.36 |
| 5 years | 0.25 | | 20 |
| 10 years | 0.25 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jerry Katzman
CEO | Chief Executive Officer | 73 | 01/12/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Jerry Katzman
CHM | Chairman | 73 | 01/12/2018 |
Herbert Gould
BRD | Director/Board Member | 97 | 01/04/2019 |
Vinay Mehindru
BRD | Director/Board Member | 58 | 26/07/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.25% | -11.03% | +0.28% | -20.94% | 75.19M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -1.33% | -0.53% | +47.40% | +113.59% | 39.06B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.95% | +138.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -4.32M -3.84M -3.58M -3.27M -6.16M -415M -6.22M -43.36M -16.8M -212M -16.22M -15.87M -681M | -2.43M -2.16M -2.01M -1.84M -3.46M -233M -3.49M -24.37M -9.44M -119M -9.12M -8.92M -383M |
| Net Debt | 518K 460K 430K 392K 739K 49.82M 746K 5.2M 2.02M 25.47M 1.95M 1.9M 81.74M | 530K 471K 440K 401K 756K 50.95M 763K 5.32M 2.06M 26.05M 1.99M 1.95M 83.59M |
Employees
-
- Stock Market
- Stocks
- RTGN Stock
Select your edition
All financial news and data tailored to specific country editions
